DiaCarta Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:$53M
Industry:Biotech
Founded:2010
Lead Investor(s):Fortune Fountain Capital

Industry Ranking

Estimated Revenue & Financials

  • DiaCarta's estimated annual revenue is currently $7M per year.
  • DiaCarta received $45.0M in venture funding in February 2018.
  • DiaCarta's estimated revenue per employee is $155,000
  • DiaCarta's total funding is $53M.

Employee Data

  • DiaCarta has 45 Employees.
  • DiaCarta grew their employee count by 10% last year.
  • DiaCarta currently has 1 job openings.

DiaCarta is a translational genomics and personalized diagnostics company that provides ultra-sensitive detection tools for cancer diagnosis, therapy identification and prognosis monitoring. Our mission is to provide ultra-sensitive and advanced technologies that will redefine the way molecular diagnostics and translational genomics impact healthcare treatment plans and the well-being of individuals around the world. To learn more, visit http://www.diacarta.com.

keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals